October 28, 2021
Webinar
Achieving a positive assessment of novelty and non-obviousness is an important step en route to achieving a granted patent; however, it is not enough. Your claims and description must also satisfy requirements such as sufficiency, enablement and clarity. In this webinar we discuss these important requirements, comparing and contrasting the approach taken by the USPTO and EPO, and focusing on the issues raised in chemical and life sciences cases.
Topics to be discussed include:
Moderator:
Anthony Tridico
Speakers:
Amanda Murphy
Maeve O’Flynn
Conference
2024 Licensing Executives Society USA – Canada Annual Meeting
October 20-23, 2024
New Orleans
Conference
4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 8-24, 2024
Virtual
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.